# Vivo Bio Tech Ltd (VIVOBIOT)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹27
Day Change: -0.93%
52W High: ₹43.35
52W Low: ₹20.35
Market Cap: ₹61 Cr

## Valuation
P/E: 11.98
P/B: 0.55
EPS: ₹2.3
Book Value: ₹50.13
Dividend Yield: 0%

## Returns
1Y Return: -33.95%

## Profitability
ROE: 15.22%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Vivo Bio Tech Ltd is a Biotechnology company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Biotechnology
Sub Industry: Unknown

## Business Model
Overview: Vivo Bio Tech Ltd makes money through Technology services, Digital transformation projects, Maintenance and managed services in Biotechnology. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Technology services
- Digital transformation projects
- Maintenance and managed services
Operating Model:
- Wins client contracts, deploys skilled delivery teams, and earns project or recurring service revenue.
- Utilisation, billing rates, attrition, and currency movements are key operating levers.
Recent Context:
- Announcement: Report On Re-Lodgement Of Transfer Requests Of Physical Shares
- Announcement: Report On Re-Lodgement Of Transfer Requests Of Physical Shares
- BSE Filing: Report On Re-Lodgement Of Transfer Requests Of Physical Shares

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-19T09:15:19.742Z
Price History Updated: 2026-05-25T05:41:54.859Z
Latest Price History Date: 2026-05-19
Technicals Updated: 2026-05-25T05:41:54.859Z
Quant Updated: 2026-05-25T05:41:54.859Z
Sentiment Updated: 2026-05-25T05:41:54.859Z
Financials Status: current
Financials Updated: 2026-05-18T13:30:00.909Z
Financials Last Attempt: 2026-05-18T13:30:00.909Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2015)
Revenue: ₹16.13 Cr
Operating Profit: ₹1.75 Cr (OPM 10.85%)
Net Profit: ₹0.29 Cr
Tax: ₹0.68 Cr

## Annual P&L History
Mar 2015: Rev ₹16.13Cr | PAT ₹0.29Cr | OPM 10.85%
Mar 2016: Rev ₹17.79Cr | PAT ₹0.46Cr | OPM 15.74%
Mar 2017: Rev ₹28.58Cr | PAT ₹0.91Cr | OPM 12.98%

## Balance Sheet (Mar 2015)
Total Assets: ₹40.04 Cr
Total Liabilities: ₹40.04 Cr
Borrowings: ₹6.62 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/vivobiot
Disclaimer: For research and education only. Not investment advice.